72
Participants
Start Date
November 30, 2005
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Memantine
Week 0: 5 mg memantine or placebo once a day (q.d.) Week 1: 5 mg memantine or placebo twice a day (b.i.d.) Week 2-3: 5 mg memantine or placebo once in the morning (q.a.m.)/10 mg once in the evening (q.p.m.) Week 4-12: 10mg Memantine or placebo b.i.d.
Placebo
Inactive comparator. Placebo-matching memantine tablet.
Asher Depression Center, Northwestern University, Chicago
Cedars Sinai Department of Psychiatry, Los Angeles
Massachusetts General Hospital, Boston
Collaborators (1)
Forest Laboratories
INDUSTRY
Massachusetts General Hospital
OTHER